This is concerning , why no indication of insiders / directors buying , shares sitting at .39 now FDA approved , of course none of us know whether or not e4 is a game changer who knows anything for certain . Management woeful , the investment would be well aware of that but ,39 there's got to be something more . We paid $11 Mill and 86 M shares to Mithra after approval , who really knows if this will pay off or not nothing is for certain except death and taxes . If this was seen to be an exorbitant cost for the rights to sell Mithra owned product in the US for 20 years surely it would have invited plenty of criticism didn't see much .
MYX Price at posting:
38.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)